Five miRNAs as Novel Diagnostic Biomarker Candidates for Primary Nasopharyngeal Carcinoma
Authors:
- Zhong-Hua YuZYZhong-Hua Yu
- Tie LiuTLTie Liu
- Zi-Ying LinZLZi-Ying Lin
- Ya-Hong WangYWYa-Hong Wang
- La-Wei YangLYLa-Wei Yang
- Hui-Juan HeHHHui-Juan He
- Jun CaoJCJun Cao
- Hai-Li HuangHHHai-Li Huang
- Gang LiuGLGang Liu
Open Access
- 11 October 2014
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (18) , 7575-7581
Abstract
MicroRNAs (miRNAs) play an essential role in the development and progression of nasopharyngeal carcinomas (NPC). Despite advances in the field of cancer molecular biology and biomarker discovery, the development of clinically validated biomarkers for primary NPC has remained elusive. In this study, we investigated the expression and clinical significance of miRNAs as novel primary NPC diagnostic biomarkers. We used an array containing 2, 500 miRNAs to identify 22 significant miRNAs, and these candidate miRNAs were validated using 67 fresh NPC and 25 normal control tissues via quantitative real-time PCR (qRT-PCR). Expression and correlation analyses were performed with various statistical approaches, in addition to logistic regression and receiver operating characteristic curve analyses to evaluate diagnostic efficacy. qRT-PCR revealed five differentially expressed miRNAs (miR-93-5p, miR-135b-5p, miR-205-5p and miR-183-5p) in NPC tissue samples relative to control samples (p<0.05), with miR-135b-5p and miR-205-5p being of significant diagnostic value (p<0.01). Moreover, comparison of NPC patient clinicopathologic data revealed a negative correlation between miR-93-5p and miR- 183-5p expression levels and lymph node status (p<0.05). These findings display an altered expression of many miRNAs in NPC tissues, thus providing information pertinent to pathophysiological and diagnostic research. Ultimately, miR-135b-5p and miR-205-5p may be implicated as novel NPC candidate biomarkers, while miR- 93-5p, miR-650 and miR-183-5p may find application as relevant clinical pathology and diagnostic candidate biomarkers.Keywords
This publication has 39 references indexed in Scilit:
- The Interleukin-18 Promoter -607C>A Polymorphism Contributes to Nasopharyngeal Carcinoma Risk: Evidence from a Meta-analysis Including 1,886 SubjectsAsian Pacific Journal of Cancer Prevention, 2013
- Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypesBritish Journal of Cancer, 2013
- In-Depth Characterization of microRNA Transcriptome in MelanomaPLOS ONE, 2013
- Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patientsMolecular and Cellular Biochemistry, 2013
- miQ—A novel microRNA based diagnostic and prognostic tool for prostate cancerInternational Journal of Cancer, 2012
- Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinomaHead & Neck, 2012
- RETRACTED AND REPLACED: microRNA involvement in human cancerCarcinogenesis, 2012
- Involvement of microRNA‐93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cellsFEBS Letters, 2012
- Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency*Journal of Biological Chemistry, 2010
- MicroRNA deregulation and pathway alterations in nasopharyngeal carcinomaBritish Journal of Cancer, 2009